{"altmetric_id":1425765,"counts":{"readers":{"mendeley":148,"citeulike":2,"connotea":1},"blogs":{"unique_users_count":1,"unique_users":[55276],"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["nap"],"posts_count":1},"total":{"posts_count":7},"twitter":{"unique_users_count":3,"unique_users":["srrezaie","tony_breu","VA_Boston_CMRs"],"posts_count":4},"wikipedia":{"unique_users_count":1,"unique_users":["en:21010263"],"posts_count":1}},"selected_quotes":["Mortality is on the y-axis.","In SCD, hydroxyurea increases HbF, decrease crisis severity ( decreases mortality ( #ABIM"],"citation":{"abstract":"Hydroxyurea increases levels of fetal hemoglobin (HbF) and decreases morbidity from vaso-occlusive complications in patients with sickle cell anemia (SCA). High HbF levels reduce morbidity and mortality.","abstract_source":"pubmed","altmetric_jid":"4f6fa4ee3cf058f610002c38","authors":["Martin H. Steinberg","Franca Barton","Oswaldo Castro","Charles H. Pegelow","Samir K. Ballas","Abdullah Kutlar","Eugene Orringer","Rita Bellevue","Nancy Olivieri","James Eckman","Mala Varma","Gloria Ramirez","Brian Adler","Wally Smith","Timothy Carlos","Kenneth Ataga","Laura DeCastro","Carolyn Bigelow","Yogen Saunthararajah","Margaret Telfer","Elliott Vichinsky","Susan Claster","Susan Shurin","Kenneth Bridges","Myron Waclawiw","Duane Bonds","Michael Terrin","Steinberg, Martin H","Barton, Franca","Castro, Oswaldo","Pegelow, Charles H","Ballas, Samir K","Kutlar, Abdullah","Orringer, Eugene","Bellevue, Rita","Olivieri, Nancy","Eckman, James","Varma, Mala","Ramirez, Gloria","Adler, Brian","Smith, Wally","Carlos, Timothy","Ataga, Kenneth","DeCastro, Laura","Bigelow, Carolyn","Saunthararajah, Yogen","Telfer, Margaret","Vichinsky, Elliott","Claster, Susan","Shurin, Susan","Bridges, Kenneth","Waclawiw, Myron","Bonds, Duane","Terrin, Michael"],"doi":"10.1001\/jama.289.13.1645","first_seen_on":"2013-05-01T22:34:50+00:00","issns":["0098-7484"],"issue":"13","journal":"JAMA: Journal of the American Medical Association","last_mentioned_on":1482250880,"links":["https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12672732","http:\/\/jama.ama-assn.org\/cgi\/content\/full\/289\/13\/1645","http:\/\/dx.doi.org\/10.1001\/jama.289.13.1645","http:\/\/jama.ama-assn.org\/cgi\/content\/abstract\/289\/13\/1645","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12672732","http:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/196300"],"pdf_url":"http:\/\/jama.jamanetwork.com\/data\/Journals\/JAMA\/4874\/JOC22074.pdf","pmid":"12672732","pubdate":"2003-04-02T00:00:00+00:00","publisher":"American Medical Association","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"1645","subjects":["medicine"],"title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.","type":"article","volume":"289","mendeley_url":"http:\/\/www.mendeley.com\/research\/effect-hydroxyurea-mortality-morbidity-adult-sickle-cell-anemia-risks-benefits-up-9-years-treatment"},"altmetric_score":{"score":14.636,"score_history":{"1y":1,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":14.636},"context_for_score":{"all":{"total_number_of_other_articles":7912542,"mean":6.6949158185663,"rank":529546,"this_scored_higher_than_pct":93,"this_scored_higher_than":7382914,"rank_type":"exact","sample_size":7912542,"percentile":93},"similar_age_3m":{"total_number_of_other_articles":119060,"mean":6.8063537405825,"rank":9191,"this_scored_higher_than_pct":92,"this_scored_higher_than":109868,"rank_type":"exact","sample_size":119060,"percentile":92},"this_journal":{"total_number_of_other_articles":19463,"mean":35.389175213236,"rank":5619,"this_scored_higher_than_pct":71,"this_scored_higher_than":13843,"rank_type":"exact","sample_size":19463,"percentile":71},"similar_age_this_journal_3m":{"total_number_of_other_articles":97,"mean":44.719125,"rank":57,"this_scored_higher_than_pct":41,"this_scored_higher_than":40,"rank_type":"exact","sample_size":97,"percentile":41}}},"demographics":{"poster_types":{"member_of_the_public":1,"practitioner":2},"users":{"twitter":{"cohorts":{"Members of the public":1,"Practitioners (doctors, other healthcare professionals)":2}},"mendeley":{"by_status":{"Unspecified":2,"Professor > Associate Professor":11,"Student  > Doctoral Student":7,"Researcher":26,"Student  > Ph. D. Student":17,"Student  > Postgraduate":13,"Other":22,"Student  > Master":19,"Student  > Bachelor":21,"Lecturer":3,"Lecturer > Senior Lecturer":1,"Professor":6},"by_discipline":{"Medicine and Dentistry":76,"Social Sciences":7,"Sports and Recreations":2,"Psychology":1,"Mathematics":1,"Unspecified":5,"Environmental Science":1,"Pharmacology, Toxicology and Pharmaceutical Science":3,"Engineering":1,"Chemistry":7,"Agricultural and Biological Sciences":29,"Computer Science":2,"Business, Management and Accounting":1,"Biochemistry, Genetics and Molecular Biology":12}}},"geo":{"twitter":{"US":3},"mendeley":{"CA":1,"BD":1,"US":2,"BR":3,"GB":1,"ZA":1,"GH":1,"NG":2,"BH":1,"PT":1,"ES":3}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/srrezaie\/statuses\/329724987470667777","license":"public","citation_ids":[1425764,1425765],"posted_on":"2013-05-01T22:32:17+00:00","author":{"name":"Salim R. Rezaie","url":"http:\/\/rebelem.com","image":"https:\/\/pbs.twimg.com\/profile_images\/753869523422441472\/VzheQfKG_normal.jpg","description":"EM\/IM Doc; Founder of REBEL EM & REBEL Cast; Co-Founder of The Teaching Institute; Viva #FOAMed #FOAMcc (Tweets are opinion only)","id_on_source":"srrezaie","tweeter_id":"1167910921","geo":{"lt":29.42412,"ln":-98.49363,"country":"US"},"followers":14137},"tweet_id":"329724987470667777"},{"url":"http:\/\/twitter.com\/tony_breu\/statuses\/811240606630551552","license":"gnip","citation_ids":[1425765],"posted_on":"2016-12-20T16:03:27+00:00","author":{"name":"Tony Breu","image":"https:\/\/pbs.twimg.com\/profile_images\/752656829193326592\/jIvDMHy2_normal.jpg","description":"Hospitalist and Director of Resident Education (Medical Service), @VABostonHC. Faculty, @HMSbioethics. Mets fan. Usually at #AMreport","id_on_source":"tony_breu","tweeter_id":"545674125","geo":{"lt":42.35843,"ln":-71.05977,"country":"US"},"followers":393},"tweet_id":"811240606630551552"},{"url":"http:\/\/twitter.com\/tony_breu\/statuses\/811240803620323329","license":"gnip","citation_ids":[1425765],"posted_on":"2016-12-20T16:04:14+00:00","author":{"name":"Tony Breu","image":"https:\/\/pbs.twimg.com\/profile_images\/752656829193326592\/jIvDMHy2_normal.jpg","description":"Hospitalist and Director of Resident Education (Medical Service), @VABostonHC. Faculty, @HMSbioethics. Mets fan. Usually at #AMreport","id_on_source":"tony_breu","tweeter_id":"545674125","geo":{"lt":42.35843,"ln":-71.05977,"country":"US"},"followers":393},"tweet_id":"811240803620323329"},{"url":"http:\/\/twitter.com\/VA_Boston_CMRs\/statuses\/811245107840221184","license":"gnip","rt":["tony_breu"],"citation_ids":[1425765],"posted_on":"2016-12-20T16:21:20+00:00","author":{"name":"VA Joint Chiefs","url":"http:\/\/wikirox.com","image":"https:\/\/pbs.twimg.com\/profile_images\/875698844822122500\/9fDbTOnf_normal.jpg","description":"We are chief medical residents from @BMCimRES @BIDMChealth @BrighamWomens proudly serving New England Vets @VABostonHC. #foamed #meded Views do not represent VA","id_on_source":"VA_Boston_CMRs","tweeter_id":"2784479063","geo":{"lt":42.35843,"ln":-71.05977,"country":"US"},"followers":404},"tweet_id":"811245107840221184"}],"wikipedia":[{"title":"Sickle-cell disease","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=202805131#altmetric_citation_11","license":"public","citation_ids":[1425765,1425765,1425765],"posted_on":"2008-04-02T14:26:53+00:00","summary":"Sickle-cell disease (SCD), or sickle-cell anaemia (SCA) or sometimes drepanocytosis, is a hereditary blood disorder, characterized by an abnormality in the oxygen-carrying haemoglobin molecule in red blood cells.","page_url":"http:\/\/en.wikipedia.org\/?curid=21010263","wiki_lang":"en","author":{"name":"Jfdwolff","url":"http:\/\/en.wikipedia.org\/wiki\/User:Jfdwolff"}}],"policy":[{"title":"NIH Extramural Center Programs: Criteria for Initiation and Evaluation","url":"https:\/\/www.nap.edu\/download\/10919","license":"public","citation_ids":[14722290,1425765,14722292,8440489],"posted_on":"2004-01-01T00:00:00+00:00","source":{"name":"National Academies Press","description":"The US National Academies Press (NAP) was created by the National Academy of Sciences to publish the reports of the National Academies of Sciences, Engineering and Medicine, operating under a charter granted by the Congress of the United States. The NAP publishes on a wide range of topics in science, engineering, and medicine, providing authoritative information on important matters in science and health policy.","geo":{"country":"US"}},"page_url":"https:\/\/www.nap.edu\/catalog\/10919\/nih-extramural-center-programs-criteria-for-initiation-and-evaluation","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-95e7691171f7402a388b3749e038aa35e381ec01e37da035b7a47a1263e9de08.jpg"}}],"blogs":[{"title":"Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype","url":"http:\/\/dx.doi.org\/10.1001\/jama.2014.7192","license":"public","citation_ids":[18175108,3148527,3148527,1543544,1543544,16698106,16698106,10562192,10562192,18175117,18175117,2889296,2889296,18175129,18175129,5707362,5707362,18175142,18175142,18175148,18175148,18175153,18175153,410438,410438,3603106,3603103,3235145,3235145,4305855,4305855,18175169,18175169,18175172,18175172,6091881,6091881,18175186,18175186,18175191,18175191,18175195,18175197,18175203,18175203,18175205,18175205,6066063,6066063,4320709,4320709,18175223,18175223,18175227,1010828,1010828,727145,727145,3603086,3603086,1425765,1425765,2414925,2414925,1380861,18175234,722195,722195,516488,516488,934305,934305],"posted_on":"2014-07-01T19:59:00+00:00","summary":"Interview with John F. Tisdale, MD, author of Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype","author":{"name":"JAMA Author Interviews","url":"http:\/\/jama.jamanetwork.com\/multimedia.aspx#AuthorInterviews","description":"Interviews with Authors of JAMA Articles"}}]}}